LOINC Molecular pathology codes

Molecular pathology (MOLPATH): one class of the LOINC code system.

704 codes · page 12 of 15 · every class · by category · by group · panels · answer lists · parts

Hereditary Motor Neuropathy multigene analysis or Tissue (Blood, molecular genetics method) 103727-4 Hereditary motor and sensory neuropathy multigene analysis or Tissue (Blood, molecular genetics method) 103728-2 Hereditary sensory neuropathy multigene analysis or Tissue (Blood, molecular genetics method) 103729-0 Hereditary spastic paraplegia multigene analysis or Tissue (Blood, molecular genetics method) 103730-8 Distal weakness multigene analysis or Tissue (Blood, molecular genetics method) 103731-6 Hereditary congenital myasthenic syndrome multigene analysis or Tissue (Blood, molecular genetics method) 103732-4 Hereditary emery dreifuss multigene analysis or Tissue (Blood, molecular genetics method) 103733-2 Dyserythropoietic anemia multigene analysis in Specimen (sequencing) 103734-0 Erythrocytosis multigene analysis in Specimen (sequencing) 103735-7 Erythrocytosis focused multigene analysis in Specimen (sequencing) 103736-5 CYB5 and CYB5 Reductase multigene analysis in Specimen (sequencing) 103737-3 RBC membrane multigene analysis in Specimen (sequencing) 103738-1 EBV Lymphoproliferation multigene analysis or Tissue (Blood, molecular genetics method) 103739-9 Hyper igE syndrome multigene analysis in Specimen (molecular genetics method) 103740-7 Dysregulation autoimmune multigene analysis in Specimen (molecular genetics method) 103741-5 Viral Susceptibility multigene analysis in Specimen (molecular genetics method) 103742-3 Autoimmune lymphoproliferative syndrome multigene analysis in Specimen (molecular genetics method) 103743-1 Tripartite motif containing 46 in Specimen (qualitative, immunofluorescence) 103843-9 HISGT Histone genes targeted mutation analysis in Tumor (molecular genetics method) 104062-5 Breast Cancer recurrence risk multigene analysis (Tissue, molecular genetics method) 104119-3 TRCA+TCRD gene rearrangements (Bone Marrow, fish) 104167-2 TCL-1A gene rearrangements (Bone Marrow, fish) 104168-0 D13S319 deletion (Bone Marrow, fish) 104169-8 Chronic and low grade B cell lymphoid neoplasm multigene analysis or Tissue (Blood, molecular genetics method) 104238-1 B cell non hodgkin Lymphoma multigene analysis or Tissue (Blood, molecular genetics method) 104239-9 Histiocytic neoplasm multigene analysis or Tissue (Blood, molecular genetics method) 104240-7 Plasma cell myeloma multigene analysis (Bone Marrow, molecular genetics method) 104241-5 T cell lymphoma multigene analysis or Tissue (Blood, molecular genetics method) 104242-3 Primer set in Specimen (molecular genetics method) 104271-2 Abnormal clonal sequences in Specimen (molecular genetics method nominal) 104274-6 Chromosome 5 and 9 and 15 aneuploidy (Bone Marrow, fish) 104289-4 KIT gene mutations tested for or Tissue (Blood, molecular genetics method nominal) 104291-0 PDGFRA gene mutations tested for or Tissue (Blood, molecular genetics method nominal) 104292-8 ESR1 gene mutation or Tissue (Blood, molecular genetics method nominal) 104295-1 DPYD gene.c.1905+1G>A or Tissue (Blood, qualitative, molecular genetics method) 104296-9 UGT1A9 gene.p.M33T or Tissue (Blood, qualitative, molecular genetics method) 104300-9 UGT1A9 gene.c.-2152C>T or Tissue (Blood, qualitative, molecular genetics method) 104301-7 CXCR4 gene mutations found or Tissue (Blood, molecular genetics method nominal) 104321-5 IDH1 and IDH2 gene full mutation analysis or Tissue (Blood, molecular genetics method) 104323-1 Spermatozoa.abnormal chromatin (Semen, flow cytometry (fc)) 104619-2 DNA fragmentation index (Semen, flow cytometry (fc)) 104620-0 High DNA stainability (Semen, flow cytometry (fc)) 104621-8 APOL1, Tissue or Saliva (Blood, molecular genetics method nominal) 104664-8 DPYD Activity Score or Tissue (Blood) 104665-5 CYP2B6 Activity Score or Tissue (Blood) 104666-3 CYP2C19 Activity Score or Tissue (Blood) 104667-1 CYP2C9 Activity Score or Tissue (Blood) 104668-9 CYP2D6 Activity Score or Tissue (Blood) 104669-7 Noninvasive colorectal cancer RNA and occult blood screening (Stool, qualitative) 104936-0 Offspring or Inheritance risk in Newborn (molecular genetics method narrative) 105127-5